Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• NLC India To Start Mining In Machhakata Coal Block
• P N Gadgil Jewellers Ltd IPO GMP, Issue Date, Key Dates & Financials
• European Stocks Sink Ahead of U.S. Payrolls’ Report
• Coal Ministry Allocates Orders for 3 Commercial Mines, Rs 4,500 crore Investment Potential
• SEBI To Tighten F&O Rules Despite Investor Pushback: Report

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.